Dr Richard Phoon

Senior Lecturer
Medicine, Westmead Clinical School

Telephone +61 2 9845 6962
Fax +61 2 9845 9620

Map

Research interests

Diverse clinical research interests include chronic kidney disease, glomerulonephritis and vasculitis, peritoneal dialysis, amyloidosis and Aboriginal health. Runs an active laboratory researching the role of proinflammatory cytokines and transcription factors in animal models of T-cell mediated forms of glomerulonephritis and the role of urinary and blood biomarkers in assessment of vasculitis.

Selected grants

2010

  • Sonosite M-Turbo Hand-carried Ultrasound System; Mitchell P, Thiagalingam A, Phoon R, Lindley R; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2009

  • IL-21 and its associated intracellular signalling molecule, JAK3, are important in the development of crescentic glomerulonephritis and expression of urinary and haematologic biomarkers provide clinically useful advances in monitoring disease activity; Phoon R, Harris D; Royal Australasian College of Physicians/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Phoon, R., Kitching, A., Holdsworth, S. (2008). Goodpasture's syndrome. In C Ronco, R Bellomo, J Kellum (Eds.), Critical Care Nephrology (2nd Ed.). United Kingdom: W B Saunders.

Journals

  • Langham, R., Bellomo, R., D Intini, V., Endre, Z., Hickey, B., McGuinness, S., Phoon, R., Salamon, K., Woods, J., Gallagher, M. (2014). KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury. Nephrology, 19(5), 261-265. [More Information]
  • Lopez-Vargas, P., Tong, A., Phoon, R., Chadban, S., Shen, Y., Craig, J. (2014). Knowledge deficit of patients with stage 1-4 CKD: A focus group study. Nephrology, 19(4), 234-243. [More Information]
  • Amos, L., Touissant, N., Phoon, R., Elias, T., Levidiotis, V., Campbell, S., Walker, A., Harrex, C. (2013). Increase in nephrology advanced trainee numbers in Australia and associated reduction in clinical exposure over the past decade. Internal Medicine Journal, 43(3), 287-293. [More Information]
  • Johnson, D., Atai, E., Chan, M., Phoon, R., Scott, C., Toussaint, N., Turner, G., Usherwood, T., Wiggins, K. (2013). KHA-CARI guideline: Early chronic kidney disease: detection, prevention and management. Nephrology, 18(5), 340-350. [More Information]
  • Phoon, R. (2012). Chronic kidney disease in the elderly - Assessment and management. Australian Family Physician, 41(12), 940-944. [More Information]
  • Tong, A., Lopez-Vargas, P., Howell, M., Phoon, R., Johnson, D., Campbell, D., Walker, R., Craig, J. (2012). Consumer involvement in topic and outcome selection in the development of clinical practice guidelines. Health Expectations, 15(4), 410-423. [More Information]
  • Zhou, J., Wang, Y., Lee, V., Phoon, R., Zhang, G., Wang, Y., Tan, T., Hu, M., Wang, D., Saito, M., Harris, D., Durkan, A., et al (2012). DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration. International Journal of Clinical and Experimental Medicine, 5(1), 24-33. [More Information]
  • Summers, S., Phoon, R., Odobasic, D., Dewage, L., Kitching, A., Holdsworth, S. (2011). Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis. Clinical and Experimental Immunology, 166(2), 227-234. [More Information]
  • Summers, S., Phoon, R., Ooi, J., Holdsworth, S., Kitching, R. (2011). The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. The American Journal of Pathology: cellular and molecular biology of disease, 178(2), 580-590. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Pollock, C., Phoon, R., Snelling, P., Tong, A., Salkeld, G., Webster, A., Craig, J. (2010). Quality of life of people with chronic kidney disease and cancer (QUICK) Study. Nephrology, 15(S4), 33-33. [More Information]
  • Phoon, R., Kitching, R., Jones, L., Holdsworth, S. (2009). Atorvastatin enhances humoral immune responses but does not alter renal injury inexperimental crescentic glomerulonephritis. Nephrology, 14(7), 650-657. [More Information]
  • O'Connor, K., Fulcher, D., Phoon, R. (2009). Development of Anti-Glomerular Basement Membrane Disease After Remission From Perinuclear ANCA-Associated Glomerulonephritis in a Patient With HLA Susceptibility. American Journal of Kidney Diseases. [More Information]
  • Ooi, J., Phoon, R., Holdsworth, S., Kitching, R. (2009). IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. Journal of the American Society of Nephrology, 20(5), 980-989. [More Information]
  • Phoon, R., Kitching, R., Odobasic, D., Jones, L., Semple, T., Holdsworth, S. (2008). T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. Journal of the American Society of Nephrology, 19(3), 477-485. [More Information]
  • Krishnan, A., Phoon, R., Pussell, B., Charlesworth, J., Bostock, H., Kiernan, M. (2006). Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease. Brain, 129(Pt 6), 1585-1592. [More Information]
  • Krishnan, A., Phoon, R., Pussell, B., Charlesworth, J., Bostock, H., Kiernan, M. (2006). Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease. Clinical Neurophysiology, 117(5), 992-999. [More Information]
  • Krishnan, A., Phoon, R., Russell, B., Charlesworth, J., Kiernan, M. (2006). Sensory nerve excitability and neuropathy in end stage kidney disease. Journal of Neurology, Neurosurgery and Psychiatry, 77(4), 548-551. [More Information]
  • Krishnan, A., Phoon, R., Pussell, B., Charlesworth, J., Bostock, H., Kiernan, M. (2005). Altered motor nerve excitability in end-stage kidney disease. Brain, 128(Pt 9), 2164-2174. [More Information]

2014

  • Langham, R., Bellomo, R., D Intini, V., Endre, Z., Hickey, B., McGuinness, S., Phoon, R., Salamon, K., Woods, J., Gallagher, M. (2014). KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury. Nephrology, 19(5), 261-265. [More Information]
  • Lopez-Vargas, P., Tong, A., Phoon, R., Chadban, S., Shen, Y., Craig, J. (2014). Knowledge deficit of patients with stage 1-4 CKD: A focus group study. Nephrology, 19(4), 234-243. [More Information]

2013

  • Amos, L., Touissant, N., Phoon, R., Elias, T., Levidiotis, V., Campbell, S., Walker, A., Harrex, C. (2013). Increase in nephrology advanced trainee numbers in Australia and associated reduction in clinical exposure over the past decade. Internal Medicine Journal, 43(3), 287-293. [More Information]
  • Johnson, D., Atai, E., Chan, M., Phoon, R., Scott, C., Toussaint, N., Turner, G., Usherwood, T., Wiggins, K. (2013). KHA-CARI guideline: Early chronic kidney disease: detection, prevention and management. Nephrology, 18(5), 340-350. [More Information]

2012

  • Phoon, R. (2012). Chronic kidney disease in the elderly - Assessment and management. Australian Family Physician, 41(12), 940-944. [More Information]
  • Tong, A., Lopez-Vargas, P., Howell, M., Phoon, R., Johnson, D., Campbell, D., Walker, R., Craig, J. (2012). Consumer involvement in topic and outcome selection in the development of clinical practice guidelines. Health Expectations, 15(4), 410-423. [More Information]
  • Zhou, J., Wang, Y., Lee, V., Phoon, R., Zhang, G., Wang, Y., Tan, T., Hu, M., Wang, D., Saito, M., Harris, D., Durkan, A., et al (2012). DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration. International Journal of Clinical and Experimental Medicine, 5(1), 24-33. [More Information]

2011

  • Summers, S., Phoon, R., Odobasic, D., Dewage, L., Kitching, A., Holdsworth, S. (2011). Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis. Clinical and Experimental Immunology, 166(2), 227-234. [More Information]
  • Summers, S., Phoon, R., Ooi, J., Holdsworth, S., Kitching, R. (2011). The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. The American Journal of Pathology: cellular and molecular biology of disease, 178(2), 580-590. [More Information]

2010

  • Wong, G., Howard, K., Chapman, J., Chadban, S., Pollock, C., Phoon, R., Snelling, P., Tong, A., Salkeld, G., Webster, A., Craig, J. (2010). Quality of life of people with chronic kidney disease and cancer (QUICK) Study. Nephrology, 15(S4), 33-33. [More Information]

2009

  • Phoon, R., Kitching, R., Jones, L., Holdsworth, S. (2009). Atorvastatin enhances humoral immune responses but does not alter renal injury inexperimental crescentic glomerulonephritis. Nephrology, 14(7), 650-657. [More Information]
  • O'Connor, K., Fulcher, D., Phoon, R. (2009). Development of Anti-Glomerular Basement Membrane Disease After Remission From Perinuclear ANCA-Associated Glomerulonephritis in a Patient With HLA Susceptibility. American Journal of Kidney Diseases. [More Information]
  • Ooi, J., Phoon, R., Holdsworth, S., Kitching, R. (2009). IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. Journal of the American Society of Nephrology, 20(5), 980-989. [More Information]

2008

  • Phoon, R., Kitching, A., Holdsworth, S. (2008). Goodpasture's syndrome. In C Ronco, R Bellomo, J Kellum (Eds.), Critical Care Nephrology (2nd Ed.). United Kingdom: W B Saunders.
  • Phoon, R., Kitching, R., Odobasic, D., Jones, L., Semple, T., Holdsworth, S. (2008). T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. Journal of the American Society of Nephrology, 19(3), 477-485. [More Information]

2006

  • Krishnan, A., Phoon, R., Pussell, B., Charlesworth, J., Bostock, H., Kiernan, M. (2006). Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease. Brain, 129(Pt 6), 1585-1592. [More Information]
  • Krishnan, A., Phoon, R., Pussell, B., Charlesworth, J., Bostock, H., Kiernan, M. (2006). Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease. Clinical Neurophysiology, 117(5), 992-999. [More Information]
  • Krishnan, A., Phoon, R., Russell, B., Charlesworth, J., Kiernan, M. (2006). Sensory nerve excitability and neuropathy in end stage kidney disease. Journal of Neurology, Neurosurgery and Psychiatry, 77(4), 548-551. [More Information]

2005

  • Krishnan, A., Phoon, R., Pussell, B., Charlesworth, J., Bostock, H., Kiernan, M. (2005). Altered motor nerve excitability in end-stage kidney disease. Brain, 128(Pt 9), 2164-2174. [More Information]

To update your profile click here. For support on your academic profile contact .